6-32041892-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001365276.2(TNXB):c.12512G>A(p.Arg4171His) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0041 ( 8 hom., cov: 12)
Exomes 𝑓: 0.00066 ( 13 hom. )
Consequence
TNXB
NM_001365276.2 missense
NM_001365276.2 missense
Scores
5
12
Clinical Significance
Conservation
PhyloP100: 0.230
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.009919435).
BP6
Variant 6-32041892-C-T is Benign according to our data. Variant chr6-32041892-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 224352.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS2
High Homozygotes in GnomAd4 at 8 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNXB | NM_001365276.2 | c.12512G>A | p.Arg4171His | missense_variant | 43/44 | ENST00000644971.2 | NP_001352205.1 | |
TNXB | NM_019105.8 | c.12506G>A | p.Arg4169His | missense_variant | 43/44 | NP_061978.6 | ||
TNXB | NM_032470.4 | c.1799G>A | p.Arg600His | missense_variant | 12/13 | NP_115859.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNXB | ENST00000644971.2 | c.12512G>A | p.Arg4171His | missense_variant | 43/44 | NM_001365276.2 | ENSP00000496448 |
Frequencies
GnomAD3 genomes AF: 0.00406 AC: 396AN: 97580Hom.: 8 Cov.: 12
GnomAD3 genomes
AF:
AC:
396
AN:
97580
Hom.:
Cov.:
12
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00124 AC: 140AN: 113134Hom.: 8 AF XY: 0.00105 AC XY: 64AN XY: 60982
GnomAD3 exomes
AF:
AC:
140
AN:
113134
Hom.:
AF XY:
AC XY:
64
AN XY:
60982
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000660 AC: 394AN: 596974Hom.: 13 Cov.: 6 AF XY: 0.000515 AC XY: 162AN XY: 314618
GnomAD4 exome
AF:
AC:
394
AN:
596974
Hom.:
Cov.:
6
AF XY:
AC XY:
162
AN XY:
314618
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00406 AC: 397AN: 97678Hom.: 8 Cov.: 12 AF XY: 0.00412 AC XY: 187AN XY: 45362
GnomAD4 genome
AF:
AC:
397
AN:
97678
Hom.:
Cov.:
12
AF XY:
AC XY:
187
AN XY:
45362
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
13
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Vesicoureteral reflux 8 Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine | - | - - |
TNXB-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 14, 2024 | The TNXB c.12506G>A variant is predicted to result in the amino acid substitution p.Arg4169His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 1.5% of alleles in individuals of African descent in gnomAD. This variant is located within a highly paralogous region; population data frequency should be interpreted with caution. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 20, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
.;D;D;D;D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
N;N;N
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;.;D;N;.
REVEL
Benign
Sift
Benign
.;.;T;T;.
Sift4G
Uncertain
.;.;D;D;D
Vest4
0.17, 0.27
MVP
0.51
MPC
3.4
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at